Immix Biopharma, Inc. (IMMX)
7.48
-0.36
(-4.59%)
USD |
NASDAQ |
Nov 16, 16:00
7.49
+0.01
(+0.13%)
After-Hours: 20:00
Immix Biopharma Price : 7.48 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 7.77 | 8.01 | 7.45 | 7.48 | 1.005M |
| Nov 13, 2026 | 8.25 | 8.375 | 7.66 | 7.84 | 1.028M |
| Nov 12, 2026 | 8.40 | 8.50 | 8.06 | 8.07 | 960302.0 |
| Nov 11, 2026 | 8.40 | 8.72 | 8.30 | 8.66 | 1.071M |
| Nov 10, 2026 | 8.37 | 8.77 | 8.132 | 8.35 | 825479.0 |
| Nov 09, 2026 | 8.09 | 8.89 | 7.90 | 8.57 | 1.271M |
| Nov 06, 2026 | 7.24 | 8.17 | 7.16 | 8.06 | 1.445M |
| Nov 05, 2026 | 7.86 | 7.95 | 7.12 | 7.20 | 1.415M |
| Nov 04, 2026 | 7.93 | 8.16 | 7.56 | 7.97 | 1.250M |
| Nov 03, 2026 | 7.33 | 7.80 | 7.168 | 7.71 | 1.072M |
| Nov 02, 2026 | 7.65 | 7.913 | 7.18 | 7.26 | 1.507M |
| Oct 30, 2026 | 7.86 | 8.10 | 7.56 | 7.68 | 1.382M |
| Oct 29, 2026 | 8.11 | 8.36 | 7.835 | 7.98 | 1.074M |
| Oct 28, 2026 | 7.98 | 8.21 | 7.88 | 8.125 | 1.235M |
| Oct 27, 2026 | 8.00 | 8.165 | 7.849 | 8.05 | 1.147M |
| Oct 26, 2026 | 8.17 | 8.31 | 7.99 | 8.06 | 1.116M |
| Oct 23, 2026 | 8.34 | 8.89 | 7.88 | 8.15 | 1.203M |
| Oct 22, 2026 | 8.40 | 8.73 | 8.230 | 8.35 | 817970.0 |
| Oct 21, 2026 | 8.94 | 9.10 | 8.47 | 8.51 | 1.541M |
| Oct 20, 2026 | 8.26 | 9.03 | 8.235 | 8.91 | 1.226M |
| Oct 19, 2026 | 8.05 | 8.35 | 8.00 | 8.22 | 1.302M |
| Oct 16, 2026 | 8.67 | 8.67 | 7.95 | 7.98 | 1.504M |
| Oct 15, 2026 | 8.51 | 8.905 | 8.45 | 8.68 | 1.314M |
| Oct 14, 2026 | 8.60 | 8.87 | 8.42 | 8.51 | 1.361M |
| Oct 13, 2026 | 9.10 | 9.29 | 8.66 | 8.69 | 1.484M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.67 |
| Alnylam Pharmaceuticals, Inc. | 159.73 |
| Anika Therapeutics, Inc. | 12.92 |
| Savara, Inc. | 4.465 |
| Arrowhead Pharmaceuticals, Inc. | 44.21 |
Price Related Metrics
| PEG Ratio | -1.591 |
| Price to Book Value | 1.871 |
| Earnings Yield | -11.10% |
| Market Cap | 626.92M |
| PEGY Ratio | -1.591 |